BRUKER CORP (BRKR) Stock Fundamental Analysis
USA - NASDAQ:BRKR - US1167941087 - Common Stock
33.17 USD
-0.1 (-0.3%)
33.4391 USD
+0.27 (+0.81%)
Overall BRKR gets a fundamental rating of 5 out of 10. We evaluated BRKR against 55 industry peers in the Life Sciences Tools & Services industry. While BRKR is still in line with the averages on profitability rating, there are concerns on its financial health. BRKR has a correct valuation and a medium growth rate. Finally BRKR also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
BRKR had positive earnings in the past year.
In the past year BRKR had a positive cash flow from operations.
Each year in the past 5 years BRKR has been profitable.
Each year in the past 5 years BRKR had a positive operating cash flow.
1.2 Ratios
The Return On Assets of BRKR (1.26%) is better than 65.45% of its industry peers.
The Return On Equity of BRKR (4.41%) is better than 69.09% of its industry peers.
The Return On Invested Capital of BRKR (4.48%) is better than 67.27% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRKR is significantly below the industry average of 15.96%.
The 3 year average ROIC (9.30%) for BRKR is well above the current ROIC(4.48%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROIC | 4.48% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
Looking at the Profit Margin, with a value of 2.31%, BRKR is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
BRKR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 9.69%, BRKR is in the better half of the industry, outperforming 67.27% of the companies in the same industry.
In the last couple of years the Operating Margin of BRKR has declined.
BRKR has a Gross Margin (48.54%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BRKR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKR is destroying value.
The number of shares outstanding for BRKR has been increased compared to 1 year ago.
BRKR has less shares outstanding than it did 5 years ago.
BRKR has a worse debt/assets ratio than last year.
2.2 Solvency
BRKR has an Altman-Z score of 2.07. This is not the best score and indicates that BRKR is in the grey zone with still only limited risk for bankruptcy at the moment.
BRKR's Altman-Z score of 2.07 is in line compared to the rest of the industry. BRKR outperforms 52.73% of its industry peers.
The Debt to FCF ratio of BRKR is 49.40, which is on the high side as it means it would take BRKR, 49.40 years of fcf income to pay off all of its debts.
BRKR has a Debt to FCF ratio of 49.40. This is comparable to the rest of the industry: BRKR outperforms 49.09% of its industry peers.
BRKR has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.32, BRKR is doing worse than 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Altman-Z | 2.07 |
ROIC/WACC0.48
WACC9.39%
2.3 Liquidity
A Current Ratio of 1.61 indicates that BRKR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.61, BRKR is doing worse than 70.91% of the companies in the same industry.
BRKR has a Quick Ratio of 1.61. This is a bad value and indicates that BRKR is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.68, BRKR is doing worse than 90.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 |
3. Growth
3.1 Past
BRKR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.99%.
Measured over the past years, BRKR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.95% on average per year.
The Revenue has grown by 10.36% in the past year. This is quite good.
The Revenue has been growing by 10.19% on average over the past years. This is quite good.
EPS 1Y (TTM)-16.99%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-38.46%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.41%
3.2 Future
BRKR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.50% yearly.
BRKR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.25% yearly.
EPS Next Y-14.84%
EPS Next 2Y0.75%
EPS Next 3Y5.98%
EPS Next 5Y9.5%
Revenue Next Year2.78%
Revenue Next 2Y2.24%
Revenue Next 3Y3.47%
Revenue Next 5Y3.25%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 15.43, the valuation of BRKR can be described as correct.
Based on the Price/Earnings ratio, BRKR is valued cheaply inside the industry as 92.73% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.38, BRKR is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 13.56, the valuation of BRKR can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 92.73% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BRKR to the average of the S&P500 Index (22.86), we can say BRKR is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.43 | ||
| Fwd PE | 13.56 |
4.2 Price Multiples
90.91% of the companies in the same industry are more expensive than BRKR, based on the Enterprise Value to EBITDA ratio.
BRKR's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 102.08 | ||
| EV/EBITDA | 13.59 |
4.3 Compensation for Growth
The decent profitability rating of BRKR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.72
EPS Next 2Y0.75%
EPS Next 3Y5.98%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 6.01%, BRKR is a good candidate for dividend investing.
BRKR's Dividend Yield is rather good when compared to the industry average which is at 1.09. BRKR pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, BRKR pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.01% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.81%.
BRKR has been paying a dividend for at least 10 years, so it has a reliable track record.
BRKR has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
38.32% of the earnings are spent on dividend by BRKR. This is a low number and sustainable payout ratio.
BRKR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP38.32%
EPS Next 2Y0.75%
EPS Next 3Y5.98%
33.17
-0.1 (-0.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners82.53%
Inst Owner Change3.05%
Ins Owners26.98%
Ins Owner Change0.2%
Market Cap5.03B
Analysts76.19
Price Target45.76 (37.96%)
Short Float %8.1%
Short Ratio2.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.01% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP38.32%
Div Incr Years0
Div Non Decr Years8
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.72%
Min EPS beat(2)-26.01%
Max EPS beat(2)6.57%
EPS beat(4)2
Avg EPS beat(4)-4.79%
Min EPS beat(4)-26.01%
Max EPS beat(4)6.57%
EPS beat(8)5
Avg EPS beat(8)2.53%
EPS beat(12)9
Avg EPS beat(12)4.53%
EPS beat(16)11
Avg EPS beat(16)6.67%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)2.76%
Revenue beat(4)1
Avg Revenue beat(4)-0.72%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)7
Avg Revenue beat(12)0.97%
Revenue beat(16)10
Avg Revenue beat(16)0.99%
PT rev (1m)-1.28%
PT rev (3m)-15.68%
EPS NQ rev (1m)-4.05%
EPS NQ rev (3m)-47.52%
EPS NY rev (1m)-17.43%
EPS NY rev (3m)-18.34%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.94%
Revenue NY rev (1m)-1.95%
Revenue NY rev (3m)-1.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.43 | ||
| Fwd PE | 13.56 | ||
| P/S | 1.46 | ||
| P/FCF | 102.08 | ||
| P/OCF | 30.33 | ||
| P/B | 2.79 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.59 |
EPS(TTM)2.15
EY6.48%
EPS(NY)2.45
Fwd EY7.37%
FCF(TTM)0.32
FCFY0.98%
OCF(TTM)1.09
OCFY3.3%
SpS22.69
BVpS11.89
TBVpS-5.37
PEG (NY)N/A
PEG (5Y)1.72
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROCE | 6.68% | ||
| ROIC | 4.48% | ||
| ROICexc | 4.57% | ||
| ROICexgc | 9.81% | ||
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% | ||
| FCFM | 1.43% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexcg growth 3Y-22.35%
ROICexcg growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Debt/EBITDA | 4.37 | ||
| Cap/Depr | 55.42% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.5% | ||
| Profit Quality | 61.93% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 | ||
| Altman-Z | 2.07 |
F-Score5
WACC9.39%
ROIC/WACC0.48
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.99%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-38.46%
EPS Next Y-14.84%
EPS Next 2Y0.75%
EPS Next 3Y5.98%
EPS Next 5Y9.5%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.41%
Revenue Next Year2.78%
Revenue Next 2Y2.24%
Revenue Next 3Y3.47%
Revenue Next 5Y3.25%
EBIT growth 1Y-20.95%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year20.83%
EBIT Next 3Y14.44%
EBIT Next 5Y8.69%
FCF growth 1Y-75.44%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-51.42%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%